UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549


                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934


        Date or Report (Date of earliest event reported): August 11, 2006
                                                          ---------------


                         MEDICAL MEDIA TELEVISION, INC.
             (Exact name of registrant as specified in its charter)

         Florida                      333-105840                 59-3645932
------------------------------        -----------                -----------
(State or other jurisdiction     (Commission File Number)      (IRS Employer
     of incorporation)                                       Identification No.)

8406 Benjamin Road, Suite C, Tampa, Florida                         33634
-------------------------------------------                         -----
(Address of principal executive offices)                          (Zip Code)


       Registrant's telephone number, including area code: (813) 888-7330
                                                           --------------


                                      N/A
         (Former Name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17CFR 240.13e-4(c))


<PAGE>



ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

      Information called for by this item is contained in Item 2.03 below, which
is incorporated herein by reference.

ITEM 2.03 CREATION OF A DIRECT  FINANCIAL  OBLIGATION OR AN OBLIGATION  UNDER AN
OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT

      On August 11, 2006, Medical Media Television,  Inc. (the "Company") issued
a 10% Secured Convertible  Promissory Note in the principal amount of $1,302,000
(the "Note") to Vicis  Capital  Master Fund  ("Vicis")  pursuant to the terms of
that certain Note Purchase  Agreement  (the  "Purchase  Agreement") of even date
therewith.  As consideration for the Note, Vicis (a) delivered  $790,000 in cash
(the "Cash Payment"); (b) surrendered two secured promissory notes issued by the
Company to Vicis on June 1, 2006, and June 30, 2006,  respectively,  each in the
principal  amount  of  $50,000   (collectively,   the  "June  Notes");  and  (c)
surrendered a Series AA Convertible  Debenture No. 05-0719 issued by the Company
to  Vicis  on  July  19,  2005,  in  the  principal   amount  of  $412,000  (the
"Debenture").

      At any time while the Note  remains  outstanding,  Vicis may  convert  the
outstanding  principal  balance and any accrued but unpaid  interest on the Note
into shares of the  Company's  common  stock,  par value $.0005 per share,  at a
conversion  price of $.166 per share (the  "Shares").  The Company has agreed to
register the Shares pursuant to a Registration Rights Agreement dated August 11,
2006,  a copy of which is attached as Exhibit  10.03 to this  Current  Report on
Form 8-K.

      The  principal  balance of the Note is due,  in one lump sum  payment,  on
August 10, 2007 (the "Maturity  Date"),  unless earlier  converted.  Interest on
such principal (or any balance thereof outstanding from time to time) accrues at
an annual rate of interest of ten percent (10%).  As so accrued,  interest shall
be due and payable to Vicis on the  Maturity  Date.  If the Company  commits any
Event of  Default  (as  defined  in the  Purchase  Agreement),  then the  unpaid
principal  amount of, and accrued  interest on, the Note may be  accelerated  by
Vicis and become due and payable, whereupon the interest rate shall be increased
to a rate of twenty  percent  (20%) per  annum,  subject to the  limitations  of
applicable law.

      The Purchase  Agreement contains a number of negative covenants with which
the Company must comply so long as the Note remains  outstanding.  Such negative
covenants include, but are not limited to, restrictions on the Company's ability
to (i) declare or pay any dividends or to purchase,  redeem or otherwise acquire
or retire  any  shares of the  capital  stock of the  Company;  (ii)  effect any
reclassification,  combination  or reverse stock split of the  Company's  common
stock; (iii) create, incur or assume any lien or other encumbrance (with limited
exceptions as set forth in the Purchase Agreement); (iv) create, incur or assume
(directly or indirectly) any indebtedness  (with limited exceptions as set forth
in the Purchase  Agreement);  (v) enter into a Change in Control Transaction (as
defined  in the  Purchase  Agreement);  (vi)  amend the  Company's  Articles  of
Incorporation or Bylaws; and (vii) enter into any transactions with affiliates.

      As security for the Company's obligations under the Purchase Agreement and
the  Note,  the  Company  pledged  all of the  capital  stock  of the  Company's
subsidiaries,  PetCARE Television Network, Inc., a Florida corporation,  African
American  Medical  Network,  Inc., a Florida  corporation,  and KidCARE  Medical
Television   Network,   Inc.,   a   Florida   corporation    (collectively   the
"Subsidiaries"),  pursuant to the terms of a Stock Pledge and Escrow  Agreement,
dated August 11, 2006, in the form attached  hereto as Exhibit 10.02.  Repayment
of the Note is guaranteed by the  Subsidiaries  and is also secured by a blanket
lien encumbering the assets of the Company and the Subsidiaries.


                                       2
<PAGE>

      As an  inducement  for  Vicis to  purchase  the  Note,  Philip  M.  Cohen,
President  and  Chief  Executive  Officer  of the  Company,  agreed to amend his
employment  agreement  to  include  a three  (3)  year  non-compete  clause.  In
conjunction therewith, the Company and Mr. Cohen entered into the Second Amended
Employment  Agreement  dated  August 11,  2006,  a copy of which is  attached as
Exhibit 10.11 to this Current Report on Form 8-K.

      The issuance of the Note was exempt from the registration  requirements of
the Securities Act of 1933, as amended,  pursuant to Section 4(2) of the Act for
transactions  not involving a public  offering and Rule 506  promulgated  by the
United States  Securities  and Exchange  Commission  under the Securities Act of
1933, as amended.  The Note was issued to institutional or accredited  investors
only.

      THE INFORMATION  CONTAINED  HEREIN DOES NOT CONSTITUTE AN OFFER TO SELL OR
THE SOLICITATION OF AN OFFER TO PURCHASE SECURITIES.  THE SECURITIES  REFERENCED
HEREIN HAVE NOT BEEN  REGISTERED  UNDER THE  SECURITIES ACT OF 1933, AS AMENDED,
AND MAY NOT BE OFFERED OR SOLD IN THE UNITED  STATES ABSENT  REGISTRATION  OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS.

      The foregoing  description of the Purchase Agreement,  the Note, the Stock
Pledge and Escrow  Agreement,  the  Registration  Rights  Agreement,  the Second
Amended  Employment  Agreement,  and related  agreements  is  qualified,  in its
entirety,  by  reference  to the form of each  agreement,  copies  of which  are
attached as exhibits to this Current Report on Form 8-K and are  incorporated by
reference in response to this Item 2.03.

ITEM 3.02 UNREGISTERED SALES OF EQUITY SECURITIES

      Information called for by this item is contained in Item 2.03 above, which
is incorporated herein by reference.

      The issuance of the Note was exempt from the registration  requirements of
the Securities Act of 1933, as amended,  pursuant to Section 4(2) of the Act for
transactions  not involving a public  offering and Rule 506  promulgated  by the
United States  Securities  and Exchange  Commission  under the Securities Act of
1933, as amended.  The Note was issued to institutional or accredited  investors
only.

      THE INFORMATION  CONTAINED  HEREIN DOES NOT CONSTITUTE AN OFFER TO SELL OR
THE SOLICITATION OF AN OFFER TO PURCHASE SECURITIES.  THE SECURITIES  REFERENCED
HEREIN HAVE NOT BEEN  REGISTERED  UNDER THE  SECURITIES ACT OF 1933, AS AMENDED,
AND MAY NOT BE OFFERED OR SOLD IN THE UNITED  STATES ABSENT  REGISTRATION  OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS.

ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL  OFFICERS;  ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS

Change in Board of Directors

      The Company's Board of Directors accepted the resignation of Randall Maxey
as a member of the Board of  Directors  effective  as of August  11,  2006.  The
resignation was not the result of a disagreement  with the Company on any matter
relating to the Company's operations, policies, or practices.

                                       3
<PAGE>

      The Company has provided Mr. Maxey with a copy of the foregoing disclosure
and will file any letter  received by the Company from Mr. Maxey  regarding  the
disclosure  as an  amendment  to this  Current  Report  on Form 8-K  within  two
business days after receipt.

      The Board of  Directors  has not yet  appointed a new director to fill the
vacancy created by Mr. Maxey's resignation.


               (Remainder of this page left intentionally blank.)








                                       4
<PAGE>


ITEM 9.01         FINANCIAL STATEMENTS AND EXHIBITS

(a)      Financial Statements

         None.

(b)      Pro Forma Financial Information

         None.

(c)      Exhibits

<TABLE>
<CAPTION>

Ex. No.       Date                 Description of Exhibit
-------       ----                 ----------------------
<C>           <C>                  <C>
10.00         August 11, 2006      Note Purchase Agreement by and between the Company and Vicis Capital Master Fund
                                   for a $1,302,000 loan (*)
10.01         August 11, 2006      10% Secured Convertible Promissory Note from the Company to Vicis Capital Master
                                   Fund for $1,302,000 (*)
10.02         August 11, 2006      Stock Pledge and Escrow Agreement by and between the Company and Vicis Capital
                                   Master Fund (*)
10.03         August 11, 2006      Registration Rights Agreement by and between the Company and Vicis Capital
                                   Master Fund (*)
10.04         August 11, 2006      Security Agreement by and between the Company and Vicis Capital Master Fund (*)
10.05         August 11, 2006      Guaranty Agreement by and between PetCARE Television Network, Inc. and Vicis
                                   Capital Master Fund (*)
10.06         August 11, 2006      Guaranty Agreement by and between African American Medical Network, Inc. and
                                   Vicis Capital Master Fund (*)
10.07         August 11, 2006      Guaranty Agreement by and between KidCARE Medical Television Network, Inc. and
                                   Vicis Capital Master Fund (*)
10.08         August 11, 2006      Guarantor Security Agreement by and between PetCARE Television Network, Inc. and
                                   Vicis Capital Master Fund (*)
10.09         August 11, 2006      Guarantor Security Agreement by and between African American Medical Network,
                                   Inc. and Vicis Capital Master Fund (*)
10.10         August 11, 2006      Guarantor Security Agreement by and between KidCARE Medical Television Network,
                                   Inc. and Vicis Capital Master Fund (*)
10.11         August 11, 2006      Second Amended Employment Agreement between the Company and Philip M. Cohen (*)
10.12         August 11, 2006      Resignation letter of Randall Maxey (*)

</TABLE>

--------------------------------------------------------------------------------


                                   SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                            MEDICAL MEDIA TELEVISION, INC.
                                                 (Registrant)


Date:    August 17, 2006                    By:  /s/Philip M. Cohen
                                                --------------------------------
                                                 Philip M. Cohen, President and
                                                 Chief Executive Officer





                                       5
{"company-data": {"conformed-name": "Medical Media Television, Inc.", "cik": "0001235899", "assigned-sic": "8200", "irs-number": "593645932", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-105840", "film-number": "061040522"}, "business-address": {"street1": "MEDICAL MEDIA TELEVISION, INC.", "street2": "8406 BENJAMIN ROAD, SUITE C", "city": "TAMPA", "state": "FL", "zip": "33634", "phone": "813-888-7330"}, "mail-address": {"street1": "MEDICAL MEDIA TELEVISION, INC.", "street2": "8406 BENJAMIN ROAD, SUITE C", "city": "TAMPA", "state": "FL", "zip": "33634"}, "former-company": {"former-conformed-name": "PETCARE TELEVISION NETWORK INC", "date-changed": "20030527"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

        Date or Report (Date of earliest event reported): August 11, 2006
                                                          ---------------

                         MEDICAL MEDIA TELEVISION, INC.
             (Exact name of registrant as specified in its charter)

         Florida                      333-105840                 59-3645932
------------------------------        -----------                -----------
(State or other jurisdiction     (Commission File Number)      (IRS Employer
     of incorporation)                                       Identification No.)

8406 Benjamin Road, Suite C, Tampa, Florida                         33634
-------------------------------------------                         -----
(Address of principal executive offices)                          (Zip Code)

       Registrant's telephone number, including area code: (813) 888-7330
                                                           --------------

                                      N/A
         (Former Name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17CFR 240.13e-4(c))
ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

      Information called for by this item is contained in Item 2.03 below, which
is incorporated herein by reference.

ITEM 2.03 CREATION OF A DIRECT  FINANCIAL  OBLIGATION OR AN OBLIGATION  UNDER AN
OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT

      On August 11, 2006, Medical Media Television,  Inc. (the "Company") issued
a 10% Secured Convertible  Promissory Note in the principal amount of $1,302,000
(the "Note") to Vicis  Capital  Master Fund  ("Vicis")  pursuant to the terms of
that certain Note Purchase  Agreement  (the  "Purchase  Agreement") of even date
therewith.  As consideration for the Note, Vicis (a) delivered  $790,000 in cash
(the "Cash Payment"); (b) surrendered two secured promissory notes issued by the
Company to Vicis on June 1, 2006, and June 30, 2006,  respectively,  each in the
principal  amount  of  $50,000   (collectively,   the  "June  Notes");  and  (c)
surrendered a Series AA Convertible  Debenture No. 05-0719 issued by the Company
to  Vicis  on  July  19,  2005,  in  the  principal   amount  of  $412,000  (the
"Debenture").

      At any time while the Note  remains  outstanding,  Vicis may  convert  the
outstanding  principal  balance and any accrued but unpaid  interest on the Note
into shares of the  Company's  common  stock,  par value $.0005 per share,  at a
conversion  price of $.166 per share (the  "Shares").  The Company has agreed to
register the Shares pursuant to a Registration Rights Agreement dated August 11,
2006,  a copy of which is attached as Exhibit  10.03 to this  Current  Report on
Form 8-K.

      The  principal  balance of the Note is due,  in one lump sum  payment,  on
August 10, 2007 (the "Maturity  Date"),  unless earlier  converted.  Interest on
such principal (or any balance thereof outstanding from time to time) accrues at
an annual rate of interest of ten percent (10%).  As so accrued,  interest shall
be due and payable to Vicis on the  Maturity  Date.  If the Company  commits any
Event of  Default  (as  defined  in the  Purchase  Agreement),  then the  unpaid
principal  amount of, and accrued  interest on, the Note may be  accelerated  by
Vicis and become due and payable, whereupon the interest rate shall be increased
to a rate of twenty  percent  (20%) per  annum,  subject to the  limitations  of
applicable law.

      The Purchase  Agreement contains a number of negative covenants with which
the Company must comply so long as the Note remains  outstanding.  Such negative
covenants include, but are not limited to, restrictions on the Company's ability
to (i) declare or pay any dividends or to purchase,  redeem or otherwise acquire
or retire  any  shares of the  capital  stock of the  Company;  (ii)  effect any
reclassification,  combination  or reverse stock split of the  Company's  common
stock; (iii) create, incur or assume any lien or other encumbrance (with limited
exceptions as set forth in the Purchase Agreement); (iv) create, incur or assume
(directly or indirectly) any indebtedness  (with limited exceptions as set forth
in the Purchase  Agreement);  (v) enter into a Change in Control Transaction (as
defined  in the  Purchase  Agreement);  (vi)  amend the  Company's  Articles  of
Incorporation or Bylaws; and (vii) enter into any transactions with affiliates.

      As security for the Company's obligations under the Purchase Agreement and
the  Note,  the  Company  pledged  all of the  capital  stock  of the  Company's
subsidiaries,  PetCARE Television Network, Inc., a Florida corporation,  African
American  Medical  Network,  Inc., a Florida  corporation,  and KidCARE  Medical
Television   Network,   Inc.,   a   Florida   corporation    (collectively   the
"Subsidiaries"),  pursuant to the terms of a Stock Pledge and Escrow  Agreement,
dated August 11, 2006, in the form attached  hereto as Exhibit 10.02.  Repayment
of the Note is guaranteed by the  Subsidiaries  and is also secured by a blanket
lien encumbering the assets of the Company and the Subsidiaries.

                                       2
As an  inducement  for  Vicis to  purchase  the  Note,  Philip  M.  Cohen,
President  and  Chief  Executive  Officer  of the  Company,  agreed to amend his
employment  agreement  to  include  a three  (3)  year  non-compete  clause.  In
conjunction therewith, the Company and Mr. Cohen entered into the Second Amended
Employment  Agreement  dated  August 11,  2006,  a copy of which is  attached as
Exhibit 10.11 to this Current Report on Form 8-K.

      The issuance of the Note was exempt from the registration  requirements of
the Securities Act of 1933, as amended,  pursuant to Section 4(2) of the Act for
transactions  not involving a public  offering and Rule 506  promulgated  by the
United States  Securities  and Exchange  Commission  under the Securities Act of
1933, as amended.  The Note was issued to institutional or accredited  investors
only.

      THE INFORMATION  CONTAINED  HEREIN DOES NOT CONSTITUTE AN OFFER TO SELL OR
THE SOLICITATION OF AN OFFER TO PURCHASE SECURITIES.  THE SECURITIES  REFERENCED
HEREIN HAVE NOT BEEN  REGISTERED  UNDER THE  SECURITIES ACT OF 1933, AS AMENDED,
AND MAY NOT BE OFFERED OR SOLD IN THE UNITED  STATES ABSENT  REGISTRATION  OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS.

      The foregoing  description of the Purchase Agreement,  the Note, the Stock
Pledge and Escrow  Agreement,  the  Registration  Rights  Agreement,  the Second
Amended  Employment  Agreement,  and related  agreements  is  qualified,  in its
entirety,  by  reference  to the form of each  agreement,  copies  of which  are
attached as exhibits to this Current Report on Form 8-K and are  incorporated by
reference in response to this Item 2.03.

ITEM 3.02 UNREGISTERED SALES OF EQUITY SECURITIES

      Information called for by this item is contained in Item 2.03 above, which
is incorporated herein by reference.

      The issuance of the Note was exempt from the registration  requirements of
the Securities Act of 1933, as amended,  pursuant to Section 4(2) of the Act for
transactions  not involving a public  offering and Rule 506  promulgated  by the
United States  Securities  and Exchange  Commission  under the Securities Act of
1933, as amended.  The Note was issued to institutional or accredited  investors
only.

      THE INFORMATION  CONTAINED  HEREIN DOES NOT CONSTITUTE AN OFFER TO SELL OR
THE SOLICITATION OF AN OFFER TO PURCHASE SECURITIES.  THE SECURITIES  REFERENCED
HEREIN HAVE NOT BEEN  REGISTERED  UNDER THE  SECURITIES ACT OF 1933, AS AMENDED,
AND MAY NOT BE OFFERED OR SOLD IN THE UNITED  STATES ABSENT  REGISTRATION  OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS.

ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL  OFFICERS;  ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS

Change in Board of Directors

      The Company's Board of Directors accepted the resignation of Randall Maxey
as a member of the Board of  Directors  effective  as of August  11,  2006.  The
resignation was not the result of a disagreement  with the Company on any matter
relating to the Company's operations, policies, or practices.

                                       3
The Company has provided Mr. Maxey with a copy of the foregoing disclosure
and will file any letter  received by the Company from Mr. Maxey  regarding  the
disclosure  as an  amendment  to this  Current  Report  on Form 8-K  within  two
business days after receipt.

      The Board of  Directors  has not yet  appointed a new director to fill the
vacancy created by Mr. Maxey's resignation.

               (Remainder of this page left intentionally blank.)

                                       4
ITEM 9.01         FINANCIAL STATEMENTS AND EXHIBITS

(a)      Financial Statements

         None.

(b)      Pro Forma Financial Information

         None.

(c)      Exhibits
Ex. No.       Date                 Description of Exhibit
-------       ----                 ----------------------
10.00         August 11, 2006      Note Purchase Agreement by and between the Company and Vicis Capital Master Fund
                                   for a $1,302,000 loan (*)
10.01         August 11, 2006      10% Secured Convertible Promissory Note from the Company to Vicis Capital Master
                                   Fund for $1,302,000 (*)
10.02         August 11, 2006      Stock Pledge and Escrow Agreement by and between the Company and Vicis Capital
                                   Master Fund (*)
10.03         August 11, 2006      Registration Rights Agreement by and between the Company and Vicis Capital
                                   Master Fund (*)
10.04         August 11, 2006      Security Agreement by and between the Company and Vicis Capital Master Fund (*)
10.05         August 11, 2006      Guaranty Agreement by and between PetCARE Television Network, Inc. and Vicis
                                   Capital Master Fund (*)
10.06         August 11, 2006      Guaranty Agreement by and between African American Medical Network, Inc. and
                                   Vicis Capital Master Fund (*)
10.07         August 11, 2006      Guaranty Agreement by and between KidCARE Medical Television Network, Inc. and
                                   Vicis Capital Master Fund (*)
10.08         August 11, 2006      Guarantor Security Agreement by and between PetCARE Television Network, Inc. and
                                   Vicis Capital Master Fund (*)
10.09         August 11, 2006      Guarantor Security Agreement by and between African American Medical Network,
                                   Inc. and Vicis Capital Master Fund (*)
10.10         August 11, 2006      Guarantor Security Agreement by and between KidCARE Medical Television Network,
                                   Inc. and Vicis Capital Master Fund (*)
10.11         August 11, 2006      Second Amended Employment Agreement between the Company and Philip M. Cohen (*)
10.12         August 11, 2006      Resignation letter of Randall Maxey (*)
--------------------------------------------------------------------------------

                                   SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                            MEDICAL MEDIA TELEVISION, INC.
                                                 (Registrant)

Date:    August 17, 2006                    By:  /s/Philip M. Cohen
                                                --------------------------------
                                                 Philip M. Cohen, President and
                                                 Chief Executive Officer

                                       5